ALCHEMEDICINE
Alchemedicine is a the world in drug discovery with unique technologies and ideas Innovating new drug candidates for diseases with high unmet medical needs.
ALCHEMEDICINE
Social Links:
Industry:
Biotechnology Medical Nursing And Residential Care Pharmaceutical
Founded:
2019-02-25
Address:
Tsukuba, Ibaraki, Japan
Country:
Japan
Website Url:
http://www.alchemedicine.com
Total Employee:
1+
Status:
Active
Contact:
029-898-9993
Total Funding:
1.01 B JPY
Technology used in webpage:
Euro Pound Sterling Japanese Yen Japanese Server Location
Similar Organizations
BioIntervene
BioIntervene is engages in drug discovery and development.
Dizal Pharma
Dizal Pharma is a research-based biotechnology company.
Hua Medicine
Hua Medicine is a clinical-stage, innovative drug development company in China.
LaNova Medicines
LaNova Medicines is a clinical-stage innovative drug research and development company.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Primoris Therapeutics
Primoris Therapeutics is a medical research and development center.
Sciwind Biosciences
Sciwind Biosciences is a drug research and development company for metabolic diseases.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Current Employees Featured
Founder
Investors List
SMBC Venture Capital
SMBC Venture Capital investment in Series A - Alchemedicine
Beyond Next Ventures
Beyond Next Ventures investment in Series A - Alchemedicine
Joyo Bank
Joyo Bank investment in Series A - Alchemedicine
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series A - Alchemedicine
JAFCO
JAFCO investment in Series A - Alchemedicine
Tsukuba Institute of Research
Tsukuba Institute of Research investment in Series A - Alchemedicine
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Seed Round - Alchemedicine
Beyond Next Ventures
Beyond Next Ventures investment in Seed Round - Alchemedicine
Official Site Inspections
http://www.alchemedicine.com Semrush global rank: 8.5 M Semrush visits lastest month: 523
- Host name: www1072.onamae.ne.jp
- IP address: 160.251.148.150
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "Alchemedicine"
Top | Alchemedicine, Inc.
2022.01.01. 20022年3月6日開催のキャリアフェアに参加します. 2022.01.01. 第2回tciベンチャーアワード受賞について日刊工業新聞に掲載されましたSee details»
Alchemedicine - Crunchbase Company Profile & Funding
Organization. Alchemedicine . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Alchemedicine is a biotechnology …See details»
About | Alchemedicine, Inc.
Alchemedicine, Inc. (the “Company”) operates the website, https://alchemedicine.com. By accessing, browsing or using our website, you acknowledge that you have read understood …See details»
Member | Alchemedicine, Inc.
Member. top member. home; company; pipeline; news; member; contactSee details»
Alchemedicine - Contacts, Employees, Board Members, Advisors
Alchemedicine has 1 current employee profile, Chief Executive Officer, Board Member & Chairman Keigo Tanaka. Keigo Tanaka Chief Executive Officer, Board Member & Chairman …See details»
Alchemedicine - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 16, 2021: Series A - …See details»
Alchemedicine Inc. - VentureRadar
Similar Companies: Evolva Switzerland Publicly Traded Evolva solves the supply chain issues of nature through a 21st century mix of biotechnology and fermentation. We develop, make and …See details»
Program D (Alchemedicine) - Drug Targets, Indications, Patents
Program D (Alchemedicine), Initially developed by Alchemedicine KK, Now, its global highest R&D status is Discovery, Therapeutic Areas: Congenital Disorders,Endocrinology and …See details»
alchemedicine.com - urlscan.io
Alchemedicine.com INTERQ GMO Internet,Inc, JP. Not observed on urlscan.io. General Info Open in Search Geo: Japan (JP) — Created: March 28th, 2019: AS: AS7506 - INTERQ GMO …See details»
Program C (Alchemedicine) - Drug Targets, Indications, Patents
Program C (Alchemedicine), Initially developed by Alchemedicine KK, Now, its global highest R&D status is Discovery, Therapeutic Areas: Cardiovascular Diseases, Active Indication: …See details»
Maruho and Alchemedicine Enter into Exclusive License …
Jul 3, 2023 Osaka and Ibaraki (Japan), July 3, 2023 - Maruho Co., Ltd. ("Maruho"; Head Office: Osaka; President and CEO, Atsushi Sugita) and Alchemedicine, Inc. ("Alchemedicine"; Head …See details»
Privacy | Alchemedicine, Inc.
Alchemedicine, Inc. (the “Company”) recognizes and respects the privacy rights of individuals as social obligation and key factor to run our business with social credit. Company works …See details»
Alchemedicine - Tech Stack, Apps, Patents & Trademarks
Jul 15, 2024 The intellectual property of Alchemedicine includes 8 registered patents primarily in the ' Organic Chemistry ' category, according to IPqwery. Additionally, Alchemedicine has …See details»
Alchemedicine | Portfolio | JAFCO Group Co., Ltd.
Financial Instrument Firm: Director-General of Kanto Local Finance Bureau (Kinsho) No. 1693 Member of Japan Investment Advisers Association, Type II Financial Instruments Firms …See details»
Casein kinase 1 delta/epsilon inhibitor - Alchemedicine
Casein kinase 1 delta/epsilon inhibitor is a small molecule therapeutic being developed by Alchemedicine, for the treatment of circadian rhythm disorder. The Casein kinase 1 …See details»
Autoimmune disease therapeutic - Alchemedicine - AdisInsight
A small molecule therapeutic is being developed by Alchemedicine, for the treatment of autoimmune disorders. The company utilises its HiSAP® platform to develop Autoimmune …See details»
News | Alchemedicine, Inc.
News. top news. home; company; pipeline; news; member; contactSee details»
Dry eye disease therapeutic - Alchemedicine - AdisInsight - Springer
A small molecule therapeutic is being developed by Alchemedicine, for the treatment of dry eyes. The company utilizes its HiSAP® platform to develop the Dry eye disease therapeutic - …See details»
Research programme: small molecule therapeutics
Oct 16, 2023 Small molecule therapeutics are being developed by Alchemedicine, for the treatment of an undisclosed indication. The company utilises its HiSAP® platform to Research …See details»
Rare disease therapeutic - Alchemedicine - AdisInsight - Springer
10 Oct 2023 Rare disease therapeutic - Alchemedicine is available for licensing as of 10 Oct 2023. https: ... If your organization or you do not have a subscription, try one of the following: …See details»